After receiving multiple adverse events reports, the FDA wrote a letter to providers urging for heightened patient monitoring. Here’s what you should know. 1. Providers reported two adverse events.

The US Food and Drug Administration (FDA) on Thursday sent a letter to health care providers noting the receipt of dozens of reports for two different types of adverse events linked to fluid-filled ...

Add Yahoo as a preferred source to see more of our stories on Google. Recently, Louisiana legislators voted on House Bill 581, which is aimed at prohibiting the intentional release of inflated ...